XML 229 R81.htm IDEA: XBRL DOCUMENT v3.25.0.1
SHAREHOLDERS' EQUITY - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Shares        
Balance at the beginning of the period (in shares) 1,011,170      
Balance at the end of the period (in shares) 832,614 1,011,170    
Weighted Average Exercise Price        
Proceeds from exercise of stock options $ 9   $ 4  
Equity Incentive Plan        
STOCK BASED COMPENSATION        
Number of common stock reserved for issuance 3,000,000      
Maximum number of shares that may be subject to grants of options to an individual in a calendar year 1,000,000      
Shares        
Balance at the beginning of the period (in shares) 1,011,000 448,000 617,000  
Granted (in shares)   630,000    
Exercised (in shares) (8,000)      
Forfeited (in shares) (75,000) (67,000) (159,000)  
Expired (in shares) (95,000)   (10,000)  
Balance at the end of the period (in shares) 833,000 1,011,000 448,000 617,000
Exercisable at the end of the period (in shares) 448,000      
Weighted Average Exercise Price        
Balance at the beginning of the period (in dollars per share) $ 9.69 $ 13.43 $ 13.43  
Granted (in dollars per share)   7.22    
Exercised (in dollars per share) 7.1      
Forfeited (in dollars per share) 10.56 11.45 12.27  
Expired (in dollars per share) 16.7   28.7  
Balance at the end of the period (in dollars per share) 8.84 $ 9.69 $ 13.43 $ 13.43
Exercisable (in dollars per share) $ 10.23      
Weighted Average Remaining Contractual Life        
Outstanding at the end of the period 2 years 8 months 12 days 3 years 2 years 7 months 6 days 4 years 2 months 12 days
Exercisable period of options 2 years      
Intrinsic Value        
Outstanding at the beginning of the period (in dollars) $ 61   $ 53  
Exercised (in dollars) 6      
Forfeited (in dollars) 49 $ 3 $ 2  
Outstanding at the end of the period (in dollars) 352 $ 61   $ 53
Exercisable at the end of the period (in dollars) $ 115      
Employees and Directors        
Shares        
Granted (in shares) 0 600,000    
Weighted Average Exercise Price        
Granted (in dollars per share)   $ 7.22    
Intrinsic Value        
Vesting period of options   3 years    
Exercise period of options   5 years